Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
MGMTai: O6-methylguanine-DNA methyltransferase (MGMT) methylation prediction in isocitrate dehydrogenase (IDH)-wild type glioblastoma to direct temozolomide therapy.
Journal: Neuro-oncology advances
Published: January 09, 2026
Metformin exposure after glioblastoma diagnosis and mortality: A large population-based study.
Journal: Neuro-oncology advances
Published: September 09, 2025
Contrast enhancement, G-CIMP subtype, and CDKN2A/B homozygous deletion in IDH-mutant astrocytoma.
Journal: Neuro-oncology advances
Published: July 24, 2025
What single-cell RNA sequencing taught us about MGMT expression in glioblastoma.
Journal: Neuro-oncology advances
Published: May 12, 2025
Single-cell RNA sequencing suggests different progenitor lineages between IDH mutant and IDHwt glioma.
Journal: Neuro-oncology advances
Published: May 02, 2025
Body mass index as a prognostic indicator of overall survival in glioblastoma: A systematic review and meta analysis.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: December 02, 2024
Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?
Journal: Current oncology reports
Published: September 02, 2024
Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM).
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: February 19, 2024
Emerging insights on management of high-grade glioma.
Journal: Chinese clinical oncology
Published: September 28, 2023
Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial.
Journal: Chinese clinical oncology
Published: December 30, 2022
Concurrent chemoradiation and Tumor Treating Fields (TTFields, 200 kHz) for patients with newly diagnosed glioblastoma: patterns of progression in a single institution pilot study.
Journal: Journal of neuro-oncology
Published: August 01, 2022
Last Updated: 09/26/2026